Mylan denied preliminary injunction against GSK, Apotex

PITTSBURGH A U.S. District Court denied a motion for a preliminary injunction filed by Mylan to prevent Canadian generic drug maker Apotex from making a generic version of an extended-release antidepressant drug, Mylan said Monday.


Mylan said the U.S. District Court for the District of New Jersey erred in its decision, and it intends to appeal.



Last month, Mylan obtained a temporary restraining order from the court preventing Apotex from selling a generic version of GlaxoSmithKline’s antidepressant Paxil CR (paroxetine hydrochloride). The order also prevented GSK from supplying generic versions of the drug to Apotex.


Login or Register to post a comment.